Compugen Ltd
NASDAQ:CGEN
Compugen Ltd
NASDAQ:CGEN
Price:
2.11 USD
-2.31%
Market Closed
Updated:
May 4, 2024
Compugen Ltd
Cost of Revenue
|
Compugen Ltd
Cost of Revenue Peer Comparison
Comparables:
Q
QNRX
B
BOLT
Competitive Cost of Revenue Analysis
Latest Figures & CAGR of Competitors
Latest Figures & CAGR of Competitors
| Company | Cost of Revenue | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
|---|---|---|---|---|---|
|
|
Compugen Ltd
NASDAQ:CGEN
|
Cost of Revenue
-$2m
|
CAGR 3-Years
-222%
|
CAGR 5-Years
-14%
|
CAGR 10-Years
2%
|
|
Q
|
Quoin Pharmaceuticals Ltd
NASDAQ:QNRX
|
Cost of Revenue
N/A
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
B
|
Biolight Life Sciences Ltd
TASE:BOLT
|
Cost of Revenue
N/A
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
See Also
What is Compugen Ltd's Cost of Revenue?
Cost of Revenue
-2m
USD
-2m
USD
Based on the financial report for Dec 31, 2023, Compugen Ltd's Cost of Revenue amounts to -2m USD.
What is Compugen Ltd's Cost of Revenue growth rate?
Cost of Revenue CAGR 10Y
2%
2%
Over the last year, the Cost of Revenue growth was -104%. The average annual Cost of Revenue growth rates for Compugen Ltd have been -222% over the past three years , -14% over the past five years , and 2% over the past ten years .
You don't have any saved screeners yet
